T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma

Investigation of canine T cell immunophenotypes in canine melanomas as prognostic biomarkers for disease progression or predictive biomarkers for targeted immunotherapeutics remains in preliminary stages. We aimed to examine T cell phenotypes and function in peripheral blood mononuclear cells (PBMC)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ellen E. Sparger, Hong Chang, Ning Chin, Robert B. Rebhun, Sita S. Withers, Hung Kieu, Robert J. Canter, Arta M. Monjazeb, Michael S. Kent
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
dog
Acceso en línea:https://doaj.org/article/0cfee634520c4c68a85e229019c24a1f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0cfee634520c4c68a85e229019c24a1f
record_format dspace
spelling oai:doaj.org-article:0cfee634520c4c68a85e229019c24a1f2021-12-02T08:21:22ZT Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma2297-176910.3389/fvets.2021.772932https://doaj.org/article/0cfee634520c4c68a85e229019c24a1f2021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.772932/fullhttps://doaj.org/toc/2297-1769Investigation of canine T cell immunophenotypes in canine melanomas as prognostic biomarkers for disease progression or predictive biomarkers for targeted immunotherapeutics remains in preliminary stages. We aimed to examine T cell phenotypes and function in peripheral blood mononuclear cells (PBMC) and baseline tumor samples by flow cytometry, and to compare patient (n = 11–20) T cell phenotypes with healthy controls dogs (n = 10–20). CD3, CD4, CD8, CD25, FoxP3, Ki67, granzyme B, and interferon-γ (IFN-γ) were used to classify T cell subsets in resting and mitogen stimulated PBMCs. In a separate patient cohort (n = 11), T cells were classified using CD3, CD4, CD8, FoxP3, and granzyme B in paired PBMC and single cell suspensions of tumor samples. Analysis of flow cytometric data of individual T cell phenotypes in PBMC revealed specific T cell phenotypes including FoxP3+ and CD25+FoxP3- populations that distinguished patients from healthy controls. Frequencies of IFN-γ+ cells after ConA stimulation identified two different patient phenotypic responses, including a normal/exaggerated IFN-γ response and a lower response suggesting dysfunction. Principle component analysis of selected T cell immunophenotypes also distinguished patients and controls for T cell phenotype and revealed a clustering of patients based on metastasis detected at diagnosis. Findings supported the overall hypothesis that canine melanoma patients display a T cell immunophenotype profile that is unique from healthy pet dogs and will guide future studies designed with larger patient cohorts necessary to further characterize prognostic T cell immunophenotypes.Ellen E. SpargerHong ChangNing ChinRobert B. RebhunSita S. WithersHung KieuRobert J. CanterArta M. MonjazebMichael S. KentFrontiers Media S.A.articlemelanomacaninedogimmune profileone healthcomparative oncologyVeterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic melanoma
canine
dog
immune profile
one health
comparative oncology
Veterinary medicine
SF600-1100
spellingShingle melanoma
canine
dog
immune profile
one health
comparative oncology
Veterinary medicine
SF600-1100
Ellen E. Sparger
Hong Chang
Ning Chin
Robert B. Rebhun
Sita S. Withers
Hung Kieu
Robert J. Canter
Arta M. Monjazeb
Michael S. Kent
T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
description Investigation of canine T cell immunophenotypes in canine melanomas as prognostic biomarkers for disease progression or predictive biomarkers for targeted immunotherapeutics remains in preliminary stages. We aimed to examine T cell phenotypes and function in peripheral blood mononuclear cells (PBMC) and baseline tumor samples by flow cytometry, and to compare patient (n = 11–20) T cell phenotypes with healthy controls dogs (n = 10–20). CD3, CD4, CD8, CD25, FoxP3, Ki67, granzyme B, and interferon-γ (IFN-γ) were used to classify T cell subsets in resting and mitogen stimulated PBMCs. In a separate patient cohort (n = 11), T cells were classified using CD3, CD4, CD8, FoxP3, and granzyme B in paired PBMC and single cell suspensions of tumor samples. Analysis of flow cytometric data of individual T cell phenotypes in PBMC revealed specific T cell phenotypes including FoxP3+ and CD25+FoxP3- populations that distinguished patients from healthy controls. Frequencies of IFN-γ+ cells after ConA stimulation identified two different patient phenotypic responses, including a normal/exaggerated IFN-γ response and a lower response suggesting dysfunction. Principle component analysis of selected T cell immunophenotypes also distinguished patients and controls for T cell phenotype and revealed a clustering of patients based on metastasis detected at diagnosis. Findings supported the overall hypothesis that canine melanoma patients display a T cell immunophenotype profile that is unique from healthy pet dogs and will guide future studies designed with larger patient cohorts necessary to further characterize prognostic T cell immunophenotypes.
format article
author Ellen E. Sparger
Hong Chang
Ning Chin
Robert B. Rebhun
Sita S. Withers
Hung Kieu
Robert J. Canter
Arta M. Monjazeb
Michael S. Kent
author_facet Ellen E. Sparger
Hong Chang
Ning Chin
Robert B. Rebhun
Sita S. Withers
Hung Kieu
Robert J. Canter
Arta M. Monjazeb
Michael S. Kent
author_sort Ellen E. Sparger
title T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_short T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_full T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_fullStr T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_full_unstemmed T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
title_sort t cell immune profiles of blood and tumor in dogs diagnosed with malignant melanoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/0cfee634520c4c68a85e229019c24a1f
work_keys_str_mv AT ellenesparger tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT hongchang tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT ningchin tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT robertbrebhun tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT sitaswithers tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT hungkieu tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT robertjcanter tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT artammonjazeb tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
AT michaelskent tcellimmuneprofilesofbloodandtumorindogsdiagnosedwithmalignantmelanoma
_version_ 1718398526039261184